PHILADELPHIA - A jury in the Philadelphia Court of Common Pleas ruled Thursday in favor of a plaintiff who claimed a pharmaceutical company's diabetes drug caused his bladder cancer.
A western Pennsylvania man has filed a pharmaceutical mass tort claim against the makers of the diabetes drug Actos, alleging the product’s use led to him developing bladder cancer.
